It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

Pfizer

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Liars may get COVID-19 boosters before those in need

Commentary / World Sep 29, 2021

Liars may get COVID-19 boosters before those in need

by Max Nisen

Who will get the booster shots? Sadly, the answer is too many of the wrong people and too few of the right ones, adding more messiness to the rollout process.

Pfizer submits COVID-19 vaccine data to U.S. regulators for use in younger kids

World Sep 29, 2021

Pfizer submits COVID-19 vaccine data to U.S. regulators for use in younger kids

A Pfizer spokesperson said the company expects to start and complete its application very soon.

U.S. CDC advisers back COVID-19 booster shots for older people but not for high-risk workers

World / Science & Health Sep 24, 2021

U.S. CDC advisers back COVID-19 booster shots for older people but not for high-risk workers

Beyond older Americans, the committee also recommended the shots for all adults over 50 with underlying conditions, as well as some 18- to 49-year-olds with those conditions.

Pfizer COVID-19 shot safely bolsters antibodies in younger kids

World Sep 20, 2021

Pfizer COVID-19 shot safely bolsters antibodies in younger kids

In a trial, two shots of a 10 microgram dose — one-third of the adult shot — produced antibody levels comparable to those seen in a trial of 16- to 25-year-olds who got the adult dose.

Pfizer shot’s protection against hospitalization wanes in study

World Sep 20, 2021

Pfizer shot’s protection against hospitalization wanes in study

After four months, Moderna’s vaccine was 92% effective against hospitalization, with Pfizer’s at 77% and Johnson & Johnson's at 68%.

Contaminants found in Pfizer vaccine in cities near Tokyo and Osaka

National Sep 15, 2021

Contaminants found in Pfizer vaccine in cities near Tokyo and Osaka

All three cities did not use doses containing foreign matter but continued using doses that were not contaminated.

Japan to donate 1.3 million more AstraZeneca vaccine doses to Taiwan and Asian neighbors

National Sep 14, 2021

Japan to donate 1.3 million more AstraZeneca vaccine doses to Taiwan and Asian neighbors

Taiwan will get 500,000 more doses, bringing Japan's total donation to the island to 3.9 million, Foreign Minister Toshimitsu Motegi told reporters.

Vaccines versus COVID-19: The great immunity debate

Commentary / World Sep 8, 2021

Vaccines versus COVID-19: The great immunity debate

by Faye Flam

There’s emerging evidence that getting sick provides better protection than at least one brand of shot. But people still need to get the jab.

The Moderna vaccine makes more antibodies than Pfizer's. Does it matter?

World / Science & Health Sep 5, 2021

The Moderna vaccine makes more antibodies than Pfizer's. Does it matter?

by Jason Gale and Robert Langreth

Subtle differences between the Pfizer Inc.-BioNTech SE and Moderna Inc. vaccines are emerging across patient groups over time, but what this all means in the real world is still unclear.

Vaccine advisers to U.S. FDA face thorny question: Are COVID-19 boosters needed?

World / Science & Health | ANALYSIS Sep 3, 2021

Vaccine advisers to U.S. FDA face thorny question: Are COVID-19 boosters needed?

by Julie Steenhuysen

A fierce debate is expected around whether most Americans should get another shot rather than just those at high risk of severe illness.

BioNTech vaccines finally reach Taiwan after heated political wrangling

Asia Pacific Sep 2, 2021

BioNTech vaccines finally reach Taiwan after heated political wrangling

by Ann Wang

Taiwan has blamed China, which claims the island as its own territory, for nixing an original order from the German firm earlier this year.

Moderna's shot makes twice as many antibodies as Pfizer's, study says

World / Science & Health Sep 1, 2021

Moderna's shot makes twice as many antibodies as Pfizer's, study says

by Jason Gale and Robert Langreth

Moderna’s COVID-19 vaccine generated more than double the antibodies of a similar shot made by Pfizer and BioNTech in research that compared immune responses evoked by the two inoculations.

« 1 … 4 5 6 … 13 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times